European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement

Medication non-adherence is associated with almost 200,000 deaths annually and €80–125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-a...

Descripción completa

Detalles Bibliográficos
Autores principales: van Boven, Job FM, Tsiligianni, Ioanna, Potočnjak, Ines, Mihajlović, Jovan, Dima, Alexandra L., Nabergoj Makovec, Urska, Ágh, Tamás, Kardas, Prezmyslaw, Ghiciuc, Cristina Mihaela, Petrova, Guenka, Bitterman, Noemi, Kamberi, Fatjona, Culig, Josip, Wettermark, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544003/
https://www.ncbi.nlm.nih.gov/pubmed/34707502
http://dx.doi.org/10.3389/fphar.2021.748702
_version_ 1784589728084918272
author van Boven, Job FM
Tsiligianni, Ioanna
Potočnjak, Ines
Mihajlović, Jovan
Dima, Alexandra L.
Nabergoj Makovec, Urska
Ágh, Tamás
Kardas, Prezmyslaw
Ghiciuc, Cristina Mihaela
Petrova, Guenka
Bitterman, Noemi
Kamberi, Fatjona
Culig, Josip
Wettermark, Björn
author_facet van Boven, Job FM
Tsiligianni, Ioanna
Potočnjak, Ines
Mihajlović, Jovan
Dima, Alexandra L.
Nabergoj Makovec, Urska
Ágh, Tamás
Kardas, Prezmyslaw
Ghiciuc, Cristina Mihaela
Petrova, Guenka
Bitterman, Noemi
Kamberi, Fatjona
Culig, Josip
Wettermark, Björn
author_sort van Boven, Job FM
collection PubMed
description Medication non-adherence is associated with almost 200,000 deaths annually and €80–125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems.
format Online
Article
Text
id pubmed-8544003
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85440032021-10-26 European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement van Boven, Job FM Tsiligianni, Ioanna Potočnjak, Ines Mihajlović, Jovan Dima, Alexandra L. Nabergoj Makovec, Urska Ágh, Tamás Kardas, Prezmyslaw Ghiciuc, Cristina Mihaela Petrova, Guenka Bitterman, Noemi Kamberi, Fatjona Culig, Josip Wettermark, Björn Front Pharmacol Pharmacology Medication non-adherence is associated with almost 200,000 deaths annually and €80–125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems. Frontiers Media S.A. 2021-10-11 /pmc/articles/PMC8544003/ /pubmed/34707502 http://dx.doi.org/10.3389/fphar.2021.748702 Text en Copyright © 2021 van Boven, Tsiligianni, Potočnjak, Mihajlović, Dima, Nabergoj Makovec, Ágh, Kardas, Ghiciuc, Petrova, Bitterman, Kamberi, Culig, Wettermark and European Network to Advance Best Practices and Technology on Medication AdherencE (ENABLE). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
van Boven, Job FM
Tsiligianni, Ioanna
Potočnjak, Ines
Mihajlović, Jovan
Dima, Alexandra L.
Nabergoj Makovec, Urska
Ágh, Tamás
Kardas, Prezmyslaw
Ghiciuc, Cristina Mihaela
Petrova, Guenka
Bitterman, Noemi
Kamberi, Fatjona
Culig, Josip
Wettermark, Björn
European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement
title European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement
title_full European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement
title_fullStr European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement
title_full_unstemmed European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement
title_short European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement
title_sort european network to advance best practices and technology on medication adherence: mission statement
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544003/
https://www.ncbi.nlm.nih.gov/pubmed/34707502
http://dx.doi.org/10.3389/fphar.2021.748702
work_keys_str_mv AT vanbovenjobfm europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT tsiligianniioanna europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT potocnjakines europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT mihajlovicjovan europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT dimaalexandral europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT nabergojmakovecurska europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT aghtamas europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT kardasprezmyslaw europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT ghiciuccristinamihaela europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT petrovaguenka europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT bittermannoemi europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT kamberifatjona europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT culigjosip europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement
AT wettermarkbjorn europeannetworktoadvancebestpracticesandtechnologyonmedicationadherencemissionstatement

Ejemplares similares